Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Oliwia Bachanek-Mitura"'
Publikováno v:
SoftwareX, Vol 26, Iss , Pp 101744- (2024)
The selection of optimal segmentation metrics is a critical aspect in the development of successful algorithms. According to new research, average Hausdorff distance (HD) should be the primary metric that evaluates contour alignment. This article int
Externí odkaz:
https://doaj.org/article/474604b4fe244ed5865e49dff0330590
Autor:
Aneta Szudy-Szczyrek, Sylwia Chocholska, Oliwia Bachanek-Mitura, Olga Czabak, Radosław Mlak, Michał Szczyrek, Justyna Muzyka-Kasietczuk, Marek Hus
Publikováno v:
Annals of Agricultural and Environmental Medicine, Vol 29, Iss 1, Pp 103-109 (2021)
Introduction and objective Multiple myeloma (MM) is an incurable condition with variable clinical course. The study included a group of patients with especially poor-prognosis, individuals with relapsed/refractory multiple myeloma (RRMM) and specific
Externí odkaz:
https://doaj.org/article/7a8307a3e68d4f7999f18813e8ff6869
Publikováno v:
Hematology in Clinical Practice. 12:77-83
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eee4ccb634c0d22fd631bc47c0553356
https://doi.org/10.5603/hcp.2021.0010
https://doi.org/10.5603/hcp.2021.0010
Autor:
Radosław Mlak, Justyna Muzyka-Kasietczuk, Marek Hus, Oliwia Bachanek-Mitura, Sylwia Chocholska, Olga Czabak, Michał Szczyrek, Aneta Szudy-Szczyrek
Publikováno v:
Annals of agricultural and environmental medicine : AAEM. 29(1)
Multiple myeloma (MM) is an incurable condition with variable clinical course. The study included a group of patients with especially poor-prognosis, individuals with relapsed/refractory multiple myeloma (RRMM) and specific cytogenetic disorders. Amo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b9ae10f64d992e9b83444f91bc9c211
https://pubmed.ncbi.nlm.nih.gov/35352912
https://pubmed.ncbi.nlm.nih.gov/35352912
Autor:
Justyna Wyroślak-Najs, Michał Solecki, Grzegorz Wallner, Witold Zgodziński, Marek Majewski, Adam Skalski, Wojciech Kielan, Wojciech Hap, Julia Rudno-Rudzińska, Ewelina Frejlich, Tadeusz Wróblewski, Waldemar Patkowski, Krzysztof Zieniewicz, Krzysztof Dudek, Marek Dobosz, Cezary Płatkowski, Maciej Słodkowski, Marek Wroński, Katarzyna Kuśnierz, Justyna Kozińska, Oliwia Bachanek-Mitura, Marek Hus, Tomasz Banasiewicz, Jacek Paszkowski, Jarosław Cwaliński, Łukasz Krokowicz, Maciej Borejsza-Wysocki, Piotr Eder, Radzisław Trzciński, Adam Dziki, Michał Mik, Łukasz Dziki, Tomasz Kościński, Marek Szczepkowski, Tomasz Zieliński, Bartosz Ziółkowski
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7535a94cfefe634bd58a53aef8a958c
https://doi.org/10.53270/2021.013
https://doi.org/10.53270/2021.013
Autor:
Oliwia Bachanek-Mitura, Witold Krupski, Tomasz Gromek, Aneta Szudy-Szczyrek, Justyna Szumiło, Michał Szczyrek, Grzegorz Helbig, Karolina Chromik, Marek Hus, Zuzanna Kanduła, Andrzej Mital
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 10, Iss 1109, p 1109 (2021)
Journal of Clinical Medicine; Volume 10; Issue 5; Pages: 1109
Journal of Clinical Medicine, Vol 10, Iss 1109, p 1109 (2021)
Journal of Clinical Medicine; Volume 10; Issue 5; Pages: 1109
In April 2017 midostaurin was approved by the US Food and Drug Administration for the treatment of patients with aggressive systemic mastocytosis (ASM). So far, very limited real world data on its efficacy is available. Thirteen patients aged from 48
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2550f85026bc5a9932a30c22c6a437cc
http://europepmc.org/articles/PMC7961806
http://europepmc.org/articles/PMC7961806
Publikováno v:
Medical University of Lublin
Myelodysplastic/myeloproliferative neoplasms (MDS/MPN) are very rare clonal myeloid characterized by the simultaneous presence of both of erythrocytic and/orgranulocytic dysplasia with myeloproliferative features. The etiology of the disease remains
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f80bd618d5bff9f4090cee990ddd9c28
https://journals.viamedica.pl/hematology_in_clinical_practice/article/view/HCP.2021.0004
https://journals.viamedica.pl/hematology_in_clinical_practice/article/view/HCP.2021.0004